{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:53:58Z","timestamp":1791158038114,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI103106"],"award-info":[{"award-number":["AI103106"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA089121"],"award-info":[{"award-number":["CA089121"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA127481"],"award-info":[{"award-number":["CA127481"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.yexmp.2013.12.002","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T11:01:17Z","timestamp":1387796477000},"page":"149-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Impaired autophagy response in human hepatocellular carcinoma"],"prefix":"10.1016","volume":"96","author":[{"given":"Lili","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha K.","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Moroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swan N.","family":"Thung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanta","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2013.12.002_bb0005","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1053\/gast.2002.33411","article-title":"Hepatocellular carcinoma: diagnosis and treatment","volume":"122","author":"Befeler","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0016-5085(03)00689-9","article-title":"Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma","volume":"125","author":"Capurro","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0020","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.bbamcr.2008.12.013","article-title":"Role and regulation of autophagy in cancer","volume":"1793","author":"Chen","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0010","first-page":"31","article-title":"Elevated alphafetoprotein in benign liver disease","volume":"4","author":"Collier","year":"1998","journal-title":"Viral Hepat. Rev."},{"key":"10.1016\/j.yexmp.2013.12.002_bb0025","first-page":"15","article-title":"The role of autophagy in liver cancer: molecular mechanisms and potential therapeutic targets","volume":"1836","author":"Cui","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0030","doi-asserted-by":"crossref","first-page":"9167","DOI":"10.1158\/0008-5472.CAN-08-1573","article-title":"Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma","volume":"68","author":"Ding","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexmp.2013.12.002_bb0035","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0040","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbamcr.2008.07.014","article-title":"Autophagy: a lysosomal degradation pathway with a central role in health and disease","volume":"1793","author":"Eskelinen","year":"2009","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0050","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pbio.1000038","article-title":"Active site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2","volume":"7","author":"Feldman","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.yexmp.2013.12.002_bb0045","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/gb-2008-9-5-224","article-title":"Glypicans","volume":"9","author":"Filmus","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.yexmp.2013.12.002_bb0055","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1158\/0008-5472.CAN-03-2191","article-title":"Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma","volume":"64","author":"Hippo","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexmp.2013.12.002_bb0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.yexmp.2006.10.010","article-title":"Glypican-3: from the mutations of Simpson\u2013Golabi Genetic Syndrome to a tumor marker for human hepatocellular carcinoma","volume":"82","author":"Jakubovic","year":"2007","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.yexmp.2013.12.002_bb0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1089-3261(05)70158-6","article-title":"The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma","volume":"5","author":"Johnson","year":"2001","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.yexmp.2013.12.002_bb0070","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/cncr.22954","article-title":"Glypican-3 immunohistochemistry in liver fine needle aspirates","volume":"111","author":"Kandil","year":"2007","journal-title":"Cancer (Cancer cytopathology)"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.molcel.2009.04.026","article-title":"A role for ubiquitin in selective autophagy","volume":"34","author":"Kirkin","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-230X-12-118","article-title":"Autophagy and apoptosis-related genes in chronic liver disease and hepatocellular carcinoma","volume":"12","author":"Kotsafti","year":"2012","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.yexmp.2013.12.002_bb0090","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.22202","article-title":"Sulfatase 2 up-regulates glypican-3 promotes fibroblast growth factor signaling and decreases survival in hepatocellular carcinoma","volume":"47","author":"Lai","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0085","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/hep.25891","article-title":"Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma","volume":"56","author":"Li","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0095","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0002-9440(10)61770-1","article-title":"Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis","volume":"159","author":"Lu","year":"2001","journal-title":"Am J Pathology"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0115","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1478-3231.2005.01100.x","article-title":"Upregulation of glypican-3 expression in hepatocellular carcinoma but down regulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers","volume":"25","author":"Man","year":"2005","journal-title":"Liver Int."},{"key":"10.1016\/j.yexmp.2013.12.002_bb0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/hep.25994","article-title":"A functional screening identified five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma","volume":"57","author":"Maurel","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0100","doi-asserted-by":"crossref","first-page":"ra24","DOI":"10.1126\/scisignal.2002739","article-title":"Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice","volume":"5","author":"Menon","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.yexmp.2013.12.002_bb0110","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.humpath.2012.06.016","article-title":"Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms","volume":"44","author":"Mounajjed","year":"2013","journal-title":"Human Pathol"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0120","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.phrs.2012.07.003","article-title":"Targeting autophagy for the treatment of liver diseases","volume":"66","author":"Ni","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.yexmp.2013.12.002_bb0125","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2353\/ajpath.2010.100050","article-title":"Impaired autophagy in sporadic inclusion body myositis and in endoplasmic reticulum stress provoked cultured human muscle fibers","volume":"177","author":"Nogalska","year":"2010","journal-title":"Am J Pathology"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0130","first-page":"397","article-title":"When autophagy meets cancer through p62\/SQSTM1","volume":"2","author":"Puissant","year":"2012","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0140","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jhep.2010.07.006","article-title":"Autophagy in liver diseases","volume":"53","author":"Rautou","year":"2010","journal-title":"J Hepatology"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0145","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1016\/j.ajpath.2011.02.021","article-title":"Changes in autophagic response in patients with chronic HCV infection","volume":"178","author":"Rautou","year":"2011","journal-title":"Am J Path"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0135","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0889-8553(21)00328-9","article-title":"Epidemiology of hepatocellular carcinoma","volume":"16","author":"Rustgi","year":"1987","journal-title":"Gastroenterol Clin North America"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0155","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1478-3231.2011.02656.x","article-title":"A possible involvement of p62\/sequestosome-1 in the process of biliary epithelial autophagy and senescence in primary biliary cirrhosis","volume":"32","author":"Sasaki","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.yexmp.2013.12.002_bb0150","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/emboj.2012.32","article-title":"A lysosome-to-nucleus signaling mechanism senses and regulates the lysosomes via mTOR and TFEB","volume":"31","author":"Settembre","year":"2012","journal-title":"The EMBO J"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0160","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0168-8278(01)00025-3","article-title":"Alpha-fetoprotein: an obituary","volume":"34","author":"Sherman","year":"2001","journal-title":"J Hepatology"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0165","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1349-7006.2009.01206.x","article-title":"Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma","volume":"100","author":"Shirakawa","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.yexmp.2013.12.002_bb0170","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1101\/gad.2016211","article-title":"Autophagy-deficient mice develop multiple liver tumors","volume":"25","author":"Takamura","year":"2011","journal-title":"Genes Development"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0180","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1074\/jbc.M900301200","article-title":"An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant function of mTORC1","volume":"284","author":"Thoreen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexmp.2013.12.002_bb0175","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ng0802-339","article-title":"Molecular pathogenesis of human hepatocellular carcinoma","volume":"31","author":"Thorgeirsson","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexmp.2013.12.002_bb0185","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.humpath.2006.05.016","article-title":"Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas","volume":"37","author":"Wang","year":"2006","journal-title":"Hum Pathology"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0190","doi-asserted-by":"crossref","first-page":"18678","DOI":"10.1074\/jbc.M801855200","article-title":"A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC2 prostate cancer cells","volume":"283","author":"Wang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexmp.2013.12.002_bb0195","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/modpathol.3800436","article-title":"The glypican-3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma","volume":"18","author":"Yamauchi","year":"2005","journal-title":"Mod Pathology"},{"key":"10.1016\/j.yexmp.2013.12.002_bb0200","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1084\/jem.189.7.1101","article-title":"A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma","volume":"189","author":"Zhang","year":"1999","journal-title":"J Experimental Medicine"}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480013001482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480013001482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T02:39:48Z","timestamp":1757990388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480013001482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0014480013001482"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2013.12.002","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired autophagy response in human hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2013.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}